Nuvation Bio's IBTROZI received FDA approval for ROS1+ NSCLC, but the stock dropped sharply due to mandated costly post-marketing trials and high SG&A expenses. Despite a strong cash position and no ...

SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ -- CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075, in an international peer-reviewed ...

Only a small percentage of recently listed biotech and healthcare companies have posted share price gains in the past year, highlighting the risk of investing in the sector. Belite Bio, however, a ...

Tue, November 19, 2024 at 8:10 PM UTC Bio-Oil is mainly known for reducing stretch marks and scarring overtime, but it also helps improve signs of aging and uneven skin tone across the face and body.

Bio-Rad Laboratories, Inc. BIO is set to release second-quarter 2023 results on Aug 3 after the closing bell. The company posted adjusted earnings per share (EPS) of $3.34 in the last reported quarter ...

Treatable arrhythmias picked up by insertable cardiac monitors (ICM) were unexpectedly common in patients with a recent or remote history of myocardial infarction (MI) in a randomized trial. But the ...

The global beauty and personal care market is rapidly shifting toward "Beauty from within" approaches that improve skin condition through internal health support. In particular, the gut-skin axis has ...

Bio-Rad Laboratories, Inc. BIO is expected to release first-quarter 2024 results on May 2 after the closing bell. The company posted adjusted earnings per share (EPS) of $3.10 in the last reported ...